Showing results (211-220 of 348) with videos related to
Sort By:
Pageof 35
Inflammatory Bowel Diseases|February 17, 2024
Health Services Utilization and Specialist Care in Pediatric Inflammatory Bowel Disease: A Multiprovince Population-Based Cohort StudyM Ellen Kuenzig, Alain Bitton, Matthew W Carroll, et al.Inflammatory Bowel Diseases|January 13, 2021
Epidemiology of Inflammatory Bowel Diseases in Israel: A Nationwide Epi-Israeli IBD Research Nucleus StudyMira Y Stulman, Noa Asayag, Gili Focht, et al.Human Vaccines & Immunotherapeutics|November 12, 2016
Assessing the risk of intussusception and rotavirus vaccine safety in CanadaSteven Hawken, Robin Ducharme, Laura C Rosella, et al.Inflammatory Bowel Diseases|December 16, 2011
Alterations in the gut microbiome of children with severe ulcerative colitisSonia Michail, Matthew Durbin, Dan Turner, et al.Lancet (London, England)|October 21, 2017
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studiesSiew C Ng, Hai Yun Shi, Nima Hamidi, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 19, 2018
Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort StudyLaura E Targownik, Eric I Benchimol, Charles N Bernstein, et al.Pediatric Research|August 19, 2010
Alpha-lactalbumin in human milk alters the proteolytic degradation of soluble CD14 by forming a complexWilliam J Spencer, Andrew Binette, Tonya L Ward, et al.Journal of Crohn'S & Colitis|June 27, 2021
Inflammatory Bowel Disease Increases the Risk of Venous Thromboembolism in Children: A Population-Based Matched Cohort StudyM Ellen Kuenzig, Alain Bitton, Matthew W Carroll, et al.Journal of Crohn'S & Colitis|July 11, 2020
Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related ComplicationsLaura E Targownik, Eric I Benchimol, Charles N Bernstein, et al.Pediatric Research|March 31, 2021
Incidence and short-term outcomes of Kawasaki diseaseCal Robinson, Rahul Chanchlani, Anastasia Gayowsky, et al.Pageof 35